Advisor OS LLC Reduces Position in HCA Healthcare, Inc. (NYSE:HCA)

Advisor OS LLC lessened its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 6.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,050 shares of the company’s stock after selling 71 shares during the quarter. Advisor OS LLC’s holdings in HCA Healthcare were worth $315,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also modified their holdings of HCA. Denali Advisors LLC raised its position in shares of HCA Healthcare by 78.6% during the 4th quarter. Denali Advisors LLC now owns 2,500 shares of the company’s stock valued at $750,000 after purchasing an additional 1,100 shares during the period. Todd Asset Management LLC raised its position in shares of HCA Healthcare by 1.7% during the 4th quarter. Todd Asset Management LLC now owns 136,917 shares of the company’s stock valued at $41,096,000 after purchasing an additional 2,348 shares during the period. Keeler Thomas Management LLC bought a new stake in shares of HCA Healthcare during the 4th quarter valued at $797,000. IFP Advisors Inc raised its position in shares of HCA Healthcare by 23.2% during the 4th quarter. IFP Advisors Inc now owns 9,444 shares of the company’s stock valued at $2,835,000 after purchasing an additional 1,777 shares during the period. Finally, Y Intercept Hong Kong Ltd raised its position in shares of HCA Healthcare by 209.0% during the 4th quarter. Y Intercept Hong Kong Ltd now owns 18,587 shares of the company’s stock valued at $5,579,000 after purchasing an additional 12,571 shares during the period. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Insider Buying and Selling at HCA Healthcare

In other news, SVP Jennifer Berres sold 9,533 shares of the business’s stock in a transaction dated Friday, February 14th. The shares were sold at an average price of $322.59, for a total value of $3,075,250.47. Following the completion of the sale, the senior vice president now owns 15,412 shares in the company, valued at approximately $4,971,757.08. The trade was a 38.22 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 1.60% of the stock is owned by corporate insiders.

HCA Healthcare Price Performance

HCA stock opened at $320.55 on Friday. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $417.14. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. The company has a 50-day moving average price of $315.11 and a 200 day moving average price of $349.91. The stock has a market cap of $79.60 billion, a PE ratio of 14.59, a P/E/G ratio of 1.10 and a beta of 1.64.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period in the previous year, the business posted $5.90 earnings per share. Equities research analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be given a $0.72 dividend. This represents a $2.88 annualized dividend and a yield of 0.90%. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date is Monday, March 17th. HCA Healthcare’s payout ratio is 13.11%.

Analyst Ratings Changes

A number of analysts have issued reports on the stock. Raymond James downgraded shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a report on Friday, November 22nd. Bank of America reduced their price target on shares of HCA Healthcare from $380.00 to $370.00 and set a “buy” rating on the stock in a report on Monday, January 27th. StockNews.com downgraded shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Monday, November 4th. Wells Fargo & Company downgraded shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and reduced their price target for the company from $400.00 to $320.00 in a report on Monday, November 25th. Finally, Truist Financial dropped their price objective on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a research note on Monday, January 6th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $385.67.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.